These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 37972874

  • 1. Dual allosteric and orthosteric pharmacology of synthetic analog cannabidiol-dimethylheptyl, but not cannabidiol, on the cannabinoid CB2 receptor.
    Bouma J, Broekhuis JD, van der Horst C, Kumar P, Ligresti A, van der Stelt M, Heitman LH.
    Biochem Pharmacol; 2023 Dec; 218():115924. PubMed ID: 37972874
    [Abstract] [Full Text] [Related]

  • 2. Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol-dimethylheptyl at the type 1 and type 2 cannabinoid receptors.
    Tham M, Yilmaz O, Alaverdashvili M, Kelly MEM, Denovan-Wright EM, Laprairie RB.
    Br J Pharmacol; 2019 May; 176(10):1455-1469. PubMed ID: 29981240
    [Abstract] [Full Text] [Related]

  • 3. Cannabidiol skews biased agonism at cannabinoid CB1 and CB2 receptors with smaller effect in CB1-CB2 heteroreceptor complexes.
    Navarro G, Reyes-Resina I, Rivas-Santisteban R, Sánchez de Medina V, Morales P, Casano S, Ferreiro-Vera C, Lillo A, Aguinaga D, Jagerovic N, Nadal X, Franco R.
    Biochem Pharmacol; 2018 Nov; 157():148-158. PubMed ID: 30194918
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Peripheral, but not central effects of cannabidiol derivatives: mediation by CB(1) and unidentified receptors.
    Fride E, Ponde D, Breuer A, Hanus L.
    Neuropharmacology; 2005 Jun; 48(8):1117-29. PubMed ID: 15910887
    [Abstract] [Full Text] [Related]

  • 6. In vitro and in vivo pharmacological activity of minor cannabinoids isolated from Cannabis sativa.
    Zagzoog A, Mohamed KA, Kim HJJ, Kim ED, Frank CS, Black T, Jadhav PD, Holbrook LA, Laprairie RB.
    Sci Rep; 2020 Nov 23; 10(1):20405. PubMed ID: 33230154
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Type 1 cannabinoid receptor ligands display functional selectivity in a cell culture model of striatal medium spiny projection neurons.
    Laprairie RB, Bagher AM, Kelly ME, Dupré DJ, Denovan-Wright EM.
    J Biol Chem; 2014 Sep 05; 289(36):24845-62. PubMed ID: 25037227
    [Abstract] [Full Text] [Related]

  • 9. Enantiomeric cannabidiol derivatives: synthesis and binding to cannabinoid receptors.
    Hanus LO, Tchilibon S, Ponde DE, Breuer A, Fride E, Mechoulam R.
    Org Biomol Chem; 2005 Mar 21; 3(6):1116-23. PubMed ID: 15750656
    [Abstract] [Full Text] [Related]

  • 10. Cannabinoid receptor expression in non-small cell lung cancer. Effectiveness of tetrahydrocannabinol and cannabidiol inhibiting cell proliferation and epithelial-mesenchymal transition in vitro.
    Milian L, Mata M, Alcacer J, Oliver M, Sancho-Tello M, Martín de Llano JJ, Camps C, Galbis J, Carretero J, Carda C.
    PLoS One; 2020 Mar 21; 15(2):e0228909. PubMed ID: 32049991
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Differential Enantiomer-Specific Signaling of Cannabidiol at CB1 Receptors.
    Bosquez-Berger T, Wilson S, Iliopoulos-Tsoutsouvas C, Jiang S, Wager-Miller J, Nikas SP, Mackie KP, Makriyannis A, Straiker A.
    Mol Pharmacol; 2022 Dec 21; 102(6):259-268. PubMed ID: 36153039
    [Abstract] [Full Text] [Related]

  • 13. Investigating selectivity and bias for G protein subtypes and β-arrestins by synthetic cannabinoid receptor agonists at the cannabinoid CB1 receptor.
    Ryalls B, Patel M, Sparkes E, Banister SD, Finlay DB, Glass M.
    Biochem Pharmacol; 2024 Apr 21; 222():116052. PubMed ID: 38354957
    [Abstract] [Full Text] [Related]

  • 14. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin.
    Pertwee RG.
    Br J Pharmacol; 2008 Jan 21; 153(2):199-215. PubMed ID: 17828291
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. (+)-Cannabidiol analogues which bind cannabinoid receptors but exert peripheral activity only.
    Fride E, Feigin C, Ponde DE, Breuer A, Hanus L, Arshavsky N, Mechoulam R.
    Eur J Pharmacol; 2004 Dec 15; 506(2):179-88. PubMed ID: 15588739
    [Abstract] [Full Text] [Related]

  • 17. Cannabidiol Inhibits Endocannabinoid Signaling in Autaptic Hippocampal Neurons.
    Straiker A, Dvorakova M, Zimmowitch A, Mackie K.
    Mol Pharmacol; 2018 Jul 15; 94(1):743-748. PubMed ID: 29669714
    [Abstract] [Full Text] [Related]

  • 18. Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide.
    Bisogno T, Hanus L, De Petrocellis L, Tchilibon S, Ponde DE, Brandi I, Moriello AS, Davis JB, Mechoulam R, Di Marzo V.
    Br J Pharmacol; 2001 Oct 15; 134(4):845-52. PubMed ID: 11606325
    [Abstract] [Full Text] [Related]

  • 19. Single and combined effects of plant-derived and synthetic cannabinoids on cognition and cannabinoid-associated withdrawal signs in mice.
    Myers AM, Siegele PB, Foss JD, Tuma RF, Ward SJ.
    Br J Pharmacol; 2019 May 15; 176(10):1552-1567. PubMed ID: 29338068
    [Abstract] [Full Text] [Related]

  • 20. Allosteric Modulation of the CB1 Cannabinoid Receptor by Cannabidiol-A Molecular Modeling Study of the N-Terminal Domain and the Allosteric-Orthosteric Coupling.
    Jakowiecki J, Abel R, Orzeł U, Pasznik P, Preissner R, Filipek S.
    Molecules; 2021 Apr 23; 26(9):. PubMed ID: 33922473
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.